Literature DB >> 11596099

Epidemic of jungle yellow fever in Brazil, 2000: implications of climatic alterations in disease spread.

P F Vasconcelos1, Z G Costa, E S Travassos Da Rosa, E Luna, S G Rodrigues, V L Barros, J P Dias, H A Monteiro, O F Oliva, H B Vasconcelos, R C Oliveira, M R Sousa, J Barbosa Da Silva, A C Cruz, E C Martins, J F Travassos Da Rosa.   

Abstract

Seventy-seven human cases of sylvatic yellow fever were reported in Brazil during the period January-June 2000. The first cases were reported 1 week after New Year's day and originated at Chapada dos Veadeiros, a tourist canyon site in Goiás state, near Brasília, the Brazilian capital. The laboratory procedures used for diagnoses included serology with an IgM capture assay and plaque reduction neutralization test, virus isolation in suckling mice and C6/36 cells, and immunohistochemistry. All cases were diagnosed by at least two different laboratory procedures, with the exception of the first three fatal cases, which were diagnosed on the basis of clinical and epidemiological information. The cases were reported in eight Brazilian states as follows: Goiás with 64.9% (50 cases); Amazonas (1); Bahia (10); Distrito Federal (1); Mato Grosso (4); Minas Gerais (2); Pará (1); São Paulo (2); and Tocantins (6). Patient ages were within the following ranges: 13-74 years old (mean 34.3), 64 (84.4%) were male, especially agricultural workers (n = 30), but tourists (n = 11), carpenters (n = 4), fishermen (n = 4), students (n = 3), truck drivers (n = 3), and other people (n = 22) were also sickened. The case fatality rate was 50.6% (39/77). In Bahia state, a serologic survey that was carried out has suggested a symptomatic/asymptomatic coefficient of 1:4. Field studies developed in Distrito Federal, Goiás, and São Paulo states showed that Haemagogus janthinomys was the mosquito species associated with the transmission. A single strain was also obtained from Aedes scapularis in Bahia. Epizootic occurrence (monkey mortality) was observed in 49 municipalities mainly in Goiás state, where 40 municipalities made reports, 21 of which also diagnosed human cases. Data obtained by the National Institute of Meteorology in Brazil showed an increase in temperature and rain in December 1999 and the first 3 months of 2000 in Goiás and surrounding states, which perhaps has contributed to the intense and widespread transmission of the yellow fever virus. The relatively small number of cases probably reflects the extensive use of yellow fever 17D-vaccine during the last 3 years, in which about 45 million doses were used. During the last months of 1999, 16 and 11 yellow fever cases were reported in Tocantins and Goiás states, respectively. It is noteworthy that the last reported autochthonous cases of sylvatic yellow fever in São Paulo and Bahia, both states outside the endemic/enzootic area, had occurred in 1953 and 1948, respectively. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11596099

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  24 in total

1.  RNA interference inhibits yellow fever virus replication in vitro and in vivo.

Authors:  Carolina C Pacca; Adriana A Severino; Adriano Mondini; Paula Rahal; Solange G P D'avila; José Antonio Cordeiro; Mara Correa Lelles Nogueira; Roberta V M Bronzoni; Maurício L Nogueira
Journal:  Virus Genes       Date:  2009-01-25       Impact factor: 2.332

2.  The whole iceberg: estimating the incidence of yellow fever virus infection from the number of severe cases.

Authors:  Michael A Johansson; Pedro F C Vasconcelos; J Erin Staples
Journal:  Trans R Soc Trop Med Hyg       Date:  2014-06-30       Impact factor: 2.184

3.  Predicting Yellow Fever Through Species Distribution Modeling of Virus, Vector, and Monkeys.

Authors:  Marco A B de Almeida; Edmilson Dos Santos; Jáder da C Cardoso; Lucas G da Silva; Rafael M Rabelo; Júlio César Bicca-Marques
Journal:  Ecohealth       Date:  2018-12-17       Impact factor: 3.184

Review 4.  The global distribution of yellow fever and dengue.

Authors:  D J Rogers; A J Wilson; S I Hay; A J Graham
Journal:  Adv Parasitol       Date:  2006       Impact factor: 3.870

Review 5.  Yellow Fever Virus: Diagnostics for a Persistent Arboviral Threat.

Authors:  Jesse J Waggoner; Alejandra Rojas; Benjamin A Pinsky
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

6.  Yellow fever virus maintenance in Trinidad and its dispersal throughout the Americas.

Authors:  Albert J Auguste; Philippe Lemey; Oliver G Pybus; Marc A Suchard; Rosa Alba Salas; Abiodun A Adesiyun; Alan D Barrett; Robert B Tesh; Scott C Weaver; Christine V F Carrington
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

Review 7.  Fever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus.

Authors:  Kathryn A Hanley; Thomas P Monath; Scott C Weaver; Shannan L Rossi; Rebecca L Richman; Nikos Vasilakis
Journal:  Infect Genet Evol       Date:  2013-03-20       Impact factor: 3.342

8.  Geographic patterns and environmental factors associated with human yellow fever presence in the Americas.

Authors:  Patricia Najera Hamrick; Sylvain Aldighieri; Gustavo Machado; Deise Galan Leonel; Luz Maria Vilca; Sonia Uriona; Maria Cristina Schneider
Journal:  PLoS Negl Trop Dis       Date:  2017-09-08

9.  Emerging and Reemerging Aedes-Transmitted Arbovirus Infections in the Region of the Americas: Implications for Health Policy.

Authors:  Marcos A Espinal; Jon K Andrus; Barbara Jauregui; Stephen Hull Waterman; David Michael Morens; Jose Ignacio Santos; Olaf Horstick; Lorraine Ayana Francis; Daniel Olson
Journal:  Am J Public Health       Date:  2019-01-24       Impact factor: 9.308

10.  Genomic and epidemiological monitoring of yellow fever virus transmission potential.

Authors:  N R Faria; M U G Kraemer; S C Hill; J Goes de Jesus; R S Aguiar; F C M Iani; J Xavier; J Quick; L du Plessis; S Dellicour; J Thézé; R D O Carvalho; G Baele; C-H Wu; P P Silveira; M B Arruda; M A Pereira; G C Pereira; J Lourenço; U Obolski; L Abade; T I Vasylyeva; M Giovanetti; D Yi; D J Weiss; G R W Wint; F M Shearer; S Funk; B Nikolay; V Fonseca; T E R Adelino; M A A Oliveira; M V F Silva; L Sacchetto; P O Figueiredo; I M Rezende; E M Mello; R F C Said; D A Santos; M L Ferraz; M G Brito; L F Santana; M T Menezes; R M Brindeiro; A Tanuri; F C P Dos Santos; M S Cunha; J S Nogueira; I M Rocco; A C da Costa; S C V Komninakis; V Azevedo; A O Chieppe; E S M Araujo; M C L Mendonça; C C Dos Santos; C D Dos Santos; A M Mares-Guia; R M R Nogueira; P C Sequeira; R G Abreu; M H O Garcia; A L Abreu; O Okumoto; E G Kroon; C F C de Albuquerque; K Lewandowski; S T Pullan; M Carroll; T de Oliveira; E C Sabino; R P Souza; M A Suchard; P Lemey; G S Trindade; B P Drumond; A M B Filippis; N J Loman; S Cauchemez; L C J Alcantara; O G Pybus
Journal:  Science       Date:  2018-08-23       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.